2019PS header
MORNING AGENDA AFTERNOON AGENDA CME INFORMATION REGISTER TODAY!

 

Symposium Agenda

MORNING SESSION: BIG DATA IN PSYCHIATRY: PROMISES AND PERILS

8:30 AM–9:00 AM

Registration

9:00 AM – 9:20 AM
Welcome to Presidential Symposium and Introductions 
Mansoor A. Malik, M.D., CME Committee

9:20 AM – 9:50 AM
Big Data in Psychiatry: An Introduction and Overview 
Carlo Carandang, M.D., M.Sc. 

Carlo Caradang, MD MScCarlo is Senior Vice President at KARV, a data science consultancy in Halifax, Nova Scotia, Canada. He also functions as a data scientist and software developer for the Company. Carlo has technical expertise in machine learning, statistics, analytics, and software development. He has multiple degrees, including a Master of Science in Computing and Data Analytics from Saint Mary’s University- Halifax, MD from the University of Texas Medical Branch at Galveston, and BS in Chemical Engineering from the University of Texas at Austin. Previously a clinical researcher and psychiatry attending at multiple hospitals and medical schools in Texas, Maine, and Nova Scotia, Carlo has switched full-time into data science and now focuses on building algorithms and software for business and clinical use.

9:50 AM – 10:00 AM
Q&A

10:00 AM – 10:30 AM
Beyond Clinical Trials: Psychiatric Practice Patterns and 
Evidence Gaps in Mental Health Care 
Julie M. Zito, Ph.D.  

Julie M. Zito PhDJulie Magno Zito is Professor Emerita of Pharmacy and Psychiatry at the University of Maryland, Baltimore. She is trained in pharmacoepidemiology and has published more than 100 papers dealing with the use of psychotropic medications in community-treated populations. Her research focusing on children and adolescents has received widespread media attention. She has received more than 4 million dollars in foundation or federally funded support from NIH.

Major themes of her research include medication patterns among children and adolescents for mental health conditions, particularly among Medicaid-insured poor and vulnerable populations, e.g. foster care youth. Racial/ethnic patterns of utilization reveal large discrepancies, particularly among Hispanic youth.  Recent work includes safety studies showing the association of antipsychotic and antidepressant use and subsequent type 2 diabetes in children.

In 2008, Dr. Zito was recognized by the University of Maryland Regents with a statewide Faculty Award for Research and Scholarship. 

10:30 AM – 10:45 AM
Q&A

10:45 AM – 11:00 AM
Break

11:00 am – 11:45 am
Keynote Address – Big Data in Early Psychosis: 
Opportunities for Early Intervention in Psychiatry 
Dost Öngür, M.D., Ph.D.  

Dost Ongur MD PhDA native of Istanbul, Turkey, Dr. Öngür has a background in neuroscience and clinical psychiatry. He is currently the chief of the Psychotic Disorders Division, responsible for two inpatient units, a residential facility, and a specialty outpatient clinic. In addition to his clinical work, he receives funding from the National Institute of Mental Health and other sources for his research using brain imaging techniques to study chemical abnormalities in patients with schizophrenia and bipolar disorder. 

Dr. Öngür is currently the William P. and Henry B. Test Professor of Psychiatry at Harvard Medical School and the author of more than 80 articles on research into the neurobiology of bipolar disorder and schizophrenia. He has won awards from Harvard Medical School for his teaching of medical students and residents and for mentoring, and also serves as the associate editor of JAMA Psychiatry, a premier journal in the field.

11:45 AM – 11:55 AM
Q&A

11:55 AM – 12:15 PM
Discussant
Matthew V. Rudorfer, M.D. 

Matthew V. Rudorfer, MDDr. Rudorfer is Chief of the Somatic Treatments and Psychopharmacology Program in the Division of Services and Intervention Research at the National Institute of Mental Health (NIMH). In this position, Dr. Rudorfer helps oversee and provide scientific liaison to several multisite clinical trials, including those studying personalized treatment of depression, bipolar disorder, and early-stage psychosis, and individualized maintenance ECT and other brain stimulation interventions.  Program Chair of the annual NCDEU treatment research meeting for a dozen years, Dr. Rudorfer is also past Editor-in-Chief of the peer-reviewed Psychopharmacology Bulletin. He currently serves on the editorial boards of the Journal of ECT and CNS Drugs, and as Vice Chair of the Washington Psychiatric Society Continuing Medical Education Committee. Board Certified in Psychiatry and Clinical Pharmacology, Dr. Rudorfer received his medical degree from the State University of New York – Downstate Medical Center and trained in psychiatry at Washington University in St. Louis before coming to NIH. At present, he maintains a small private practice in psychiatry and psychopharmacology in Montgomery County, MD. 

12:15 PM – 12:45 PM
Panel / General Discussion

12:45 PM – 1:30 PM
Lunch will be served 

AFTERNOON SESSION: 21st CENTURY MODELS OF CLINICAL PRACTICE

1:30 PM – 1:40 PM
Welcome and Introductions

1:40 PM – 2:10 PM
Integrated Care Models
Joseph Parks, M.D. 

Joseph Parks MDDr. Parks currently serves as Medical Director for The National Council for Behavioral Health and is a Distinguished Research Professor of Science at Missouri Institute of Mental Health with the University of Missouri, St. Louis. He is the national behavioral health representative at large for The Joint Commission. He practices outpatient psychiatry at Family Health Center, a federally funded community health center established to expand services to uninsured and underinsured patients in Columbia Missouri. Dr. Parks has conducted research and published in the areas of implementation of evidence-based medicine, pharmacy utilization management, integration of behavioral healthcare with general healthcare, and health care policy. He has received numerous awards for improving the quality of care and leadership.

2:10 PM – 2:25 PM
Q&A

2:25 PM – 2:40 PM
Break

2:40 PM – 3:10 PM
How to be a Telesuccess: Considerations for Practicing Telepsychiatry 
Geoffrey Boyce, MBA 

Geoffrey Boyce MBAGeoffrey Boyce is the Chief Executive Officer of InSight Telepsychiatry. Boyce advocates for the appropriate use and value of telemental health and has developed unique telemedicine programs within areas of greatest need. Boyce is an active participant in telemedicine advocacy, education, and reform initiatives, regularly interacting with state and local healthcare regulators and administrators. Boyce frequently speaks about the potential of telemedicine, best practices for establishing new programs and considerations when developing telehealth legislation at organizations such as the American Telemedicine Association, Open Minds and the American Academy of Child and Adolescent Psychiatry. He also serves on the advisory board of directors for the Mid-Atlantic Telehealth Resource Center (MATRC). In April 2017, he received the Industry Leader Award from the American Telemedicine Association.

3:10 PM – 3:25 PM
Q&A

3:25 PM – 3:55 PM
Digital Psychiatry: Making Informed Decisions Around Smartphone Apps
John Torous, MD 

John Torous MDJohn Torous, MD MBI is director of the digital psychiatry division, in the Department of Psychiatry at Beth Israel Deaconess Medical Center, a Harvard Medical School-affiliated teaching hospital, where he also serves as a staff psychiatrist and academic faculty. He has a background in electrical engineering and computer sciences and received an undergraduate degree in the field from UC Berkeley before attending medical school at UC San Diego. He completed his psychiatry residency, fellowship in clinical informatics, and master’s degree in biomedical informatics at Harvard. Dr. Torous is active in investigating the potential of mobile mental health technologies for psychiatry and has published over 75 peer-reviewed articles and 5 books chapters on the topic.

3:55 PM – 4:10 PM
Q&A

4:10 PM – 4:30 PM
Wrap-up

dotted line

CME Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American Psychiatric Association (APA) and the Washington Psychiatric Society. The APA is accredited by the ACCME to provide continuing medical education for physicians. The APA designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 
dotted line
 
Registration Information 
 
FULL DAY PROGRAMIncludes breakfast and lunch.   
 

Registration Dates:

EARLY
March 4 – 18

REGULAR
March 19

LATE/ON-SITE
After April 1

 
EARLY
REGULAR
LATE/ON-SITE
 
 Regular Member
 $170
 $190
 $210
 
 RFM
 $75
 $95
$115 
 
 Non-Member
 $225
 $245
 $265
 
 HALF DAY PROGRAM – Does not include lunch.   
 
 Regular Member
 $105
 $125
 $145
 
 
 RFM
 $45
 $65
 $85
 
 
register today!
Non-Member
$160
$185
$205
 

 For more information, contact Fern Carbonell at [email protected]